BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Treatment
7353 results:

  • 1. Epidemiology, treatment and outcomes of primary renal sarcomas in adult patients.
    Uhlig J; Uhlig A; Deshpande H; Ströbel P; Trojan L; Lotz J; Hurwitz M; Hafez O; Humphrey P; Grünwald V; Kim HS
    Sci Rep; 2024 May; 14(1):10038. PubMed ID: 38693188
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma.
    Rahman SN; Long JB; Westvold SJ; Leapman MS; Spees LP; Hurwitz ME; McManus HD; Gross CP; Wheeler SB; Dinan MA
    JAMA Netw Open; 2024 Apr; 7(4):e248747. PubMed ID: 38687479
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Patient's self-reported quality of life as a prognostic factor in metastatic renal cell carcinoma initially treated with TKI: nomogram proposal.
    Lendínez-Cano G; Vilches-Arenas Á; Congregado-Ruíz B; Medina-López R
    World J Urol; 2024 Apr; 42(1):267. PubMed ID: 38678165
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate.
    Pitakkitnukun P; Pongpitakmetha T; Suttichet TB; Sukkummee W; Chariyavilaskul P; Polprasert C
    Sci Rep; 2024 Apr; 14(1):9695. PubMed ID: 38678107
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Evolution of Upper Tract Urothelial Carcinoma Management in kidney Recipients.
    Lin KJ; Chen SY; Chiang YJ; Chu SH; Liu KL; Lin CT; Pan PY; Wang HH
    Transplant Proc; 2024 Apr; 56(3):554-556. PubMed ID: 38670734
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Soluble Immune Checkpoint Molecules as Predictors of Efficacy in Immuno-Oncology Combination Therapy in Advanced Renal Cell Carcinoma.
    Ueda K; Uemura K; Ito N; Sakai Y; Ohnishi S; Suekane H; Kurose H; Hiroshige T; Chikui K; Nishihara K; Nakiri M; Suekane S; Ogasawara S; Yano H; Igawa T
    Curr Oncol; 2024 Mar; 31(4):1701-1712. PubMed ID: 38668032
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment.
    Pei F; Tao Z; Lu Q; Fang T; Peng S
    World J Surg Oncol; 2024 Apr; 22(1):110. PubMed ID: 38664770
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Management of Nontraumatic Spontaneous Renal Hemorrhage (Wünderlich Syndrome) through Robotic-Assisted Laparoscopic Nephrectomy: A Case Series.
    Tao B; Zhang H; Zhang G; Liu H; Meng L; Zhu X; Ji X; Jia G; Qi A; Wang C
    Am J Case Rep; 2024 Apr; 25():e942826. PubMed ID: 38659203
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma.
    Nakanishi S; Goya M; Suda T; Yonamine T; Sugawa A; Saito S
    BMC Urol; 2024 Apr; 24(1):94. PubMed ID: 38658967
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Oncological results of repeat partial nephrectomy in patients with recurrence after nephron-sparing procedures].
    Matveev V B; Zhumabaev N K; Komarov M I; Klimov A V; Stilidi I S
    Urologiia; 2024 Mar; (1):86-91. PubMed ID: 38650411
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland.
    Thet Z; Lam AK; Ng SK; Aung SY; Han T; Ranganathan D; Newsham S; Borg J; Pepito C; Khoo TK
    Aust J Rural Health; 2024 Apr; 32(2):249-262. PubMed ID: 38646861
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Long-term outcome of pediatric renal transplantation with donors younger than 6 years.
    Ramirez-Amoros C; San Basilio M; Amesty V; Rivas S; Lobato R; Fernandez-Camblor C; Lopez-Pereira P; Martinez-Urrutia MJ
    Pediatr Transplant; 2024 May; 28(3):e14761. PubMed ID: 38628086
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The Predictive Role of Serum Lipid Levels, p53 and ki-67, According to Molecular Subtypes in Breast Cancer: A Randomized Clinical Study.
    Faur IF; Dobrescu A; Clim IA; Pasca P; Prodan-Barbulescu C; Tarta C; Neamtu AA; Brebu D; Neamtu C; Rosu M; Duta C; Clim A; Lazar G; Totolici B
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612725
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A).
    Atkins MB; Jegede OA; Haas NB; Mcdermott DF; Bilen MA; Stein M; Sosman J; Alter R; Plimack ER; Ornstein MC; Hurwitz M; Peace DJ; Einstein D; Catalano PJ; Hammers H; Regan MM
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38604810
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Robotic salvage partial nephrectomy following surgical and ablative therapies.
    Feng CL; Franco A; Ditonno F; Manfredi C; Chow AK; Autorino R
    Int Braz J Urol; 2024; 50(3):373-374. PubMed ID: 38598832
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Discussion on the surgical timing of rupture and hemorrhage of renal angiomyolipoma].
    Chen K; Deng S; Liu Z; Zhang H; Ma L; Zhang S
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 56(2):326-331. PubMed ID: 38595253
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Conversion to Radical Nephrectomy From Robotic Partial Nephrectomy Is Most Commonly Due to Anatomic and Oncologic Complexity.
    Wang Y; Wilder S; Butaney M; Hijazi M; Gandham D; Van Til M; Goldman B; Qi J; Mirza M; Johnson A; Rudoff M; Wenzler D; Rogers CG; Lane BR
    J Urol; 2024 May; 211(5):669-676. PubMed ID: 38591701
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Percutaneous Nephrostomy as a Procedure in the treatment of Urinary Tract Obstruction - Experiences in the University Clinic of Urology in Skopje.
    Trifunovski A; Severova G; Atanasova A; Janculev J; Stankov V; Stavridis S; Saidi S; Brzanov AG; Ambardjieva M; Dohchev S
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2024 Mar; 45(1):31-40. PubMed ID: 38575377
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function.
    Sengul N; Gültürk I; Yilmaz M; Celik E; Paksoy N; Yekedüz E; Ürün Y; Basaran M; Özgüroğlu M
    Actas Urol Esp (Engl Ed); 2024 May; 48(4):273-280. PubMed ID: 38570033
    [TBL] [Abstract] [Full Text] [Related]  

  • 20.
    Miao X; Jiang P; Zhang X; Li X; Wu Z; Jiang Y; Liu H; Xie W; Li X; Shi B; Cai J; Gong W
    Microbiol Spectr; 2024 May; 12(5):e0183923. PubMed ID: 38564670
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 368.